Allergan (AGN) reports a successful Phase III trial of its treatment for overactive bladders....

|About: Allergan plc (AGN)|By:, SA News Editor

Allergan (AGN) reports a successful Phase III trial of its treatment for overactive bladders. The company says that based on the results it has pushed forward with applications to the FDA and EU to expand the range of patients approved for the medication.